A$0.175 BRN.AX stock pre-market ASX 24 Jan 2026: earnings in focus
BRN.AX stock opens pre-market at A$0.175 on 24 Jan 2026 after recent weakness and heavy trading. BrainChip Holdings Ltd (BRN.AX) listed on the ASX shows volume 8,763,763.00 and a market capitalisation of A$412,730,208.00. Investors are watching the March earnings announcement and short-term technicals for direction.
BRN.AX stock snapshot
Price and range: BRN.AX trades at A$0.175 with a day low of A$0.170 and a day high of A$0.180. Year range runs from A$0.155 to A$0.415. Volume and liquidity: today’s volume is 8,763,763.00, near the average volume of 8,567,738.00. Market context: BrainChip is listed on the ASX in Australia in the Technology sector and targets edge AI semiconductors.
Financials and valuation for BRN.AX
Earnings metrics: EPS is -0.02 and reported PE is -8.75, reflecting negative earnings. Balance and cash: shares outstanding are 2,358,458,331.00 and the company reports a current ratio of 5.18. Valuation multiples: price to book is high at 16.33, and price to sales is extreme at 214.63, signalling growth valuation on small revenue. Analyst view: external company rating shows a C- (Strong Sell) as of 22 Jan 2026, citing weak profitability.
BRN.AX stock technicals and trading signals
Momentum and volatility: the RSI reads 60.30, ATR is 0.01, and Bollinger bands sit at 0.19 / 0.17 / 0.15. Short-term indicators show overbought readings in CCI and stochastic, while ADX at 19.05 suggests no clear trend. Price averages: 50-day average is A$0.176 and 200-day average is A$0.203. Traders should watch the A$0.170–A$0.180 intraday band for immediate support and resistance.
Meyka AI grade and BRN.AX forecast
Meyka AI rates BRN.AX with a score of 64.86 out of 100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month target of A$0.19039, implying upside of 8.79% versus the current A$0.175. Forecasts are model-based projections and not guarantees. We also flag the external DCF-driven rating of C- for contrast.
Catalysts, opportunities and sector context
Near-term catalysts include the earnings release on 04 Mar 2026 and any commercial deals for the Akida neuromorphic processor. BrainChip operates in the Semiconductor industry within Australia’s Technology sector, which has delivered 1Y performance +13.07% on average. Opportunities: edge AI demand in automotive and cybersecurity could lift revenue. Investors should weigh thin revenues, high valuation multiples, and execution risk.
Risks, liquidity and trading strategy
Key risks: ongoing losses, high price-to-sales, and limited free cash flow raise dilution and funding risk. Liquidity: average daily volume supports active trading, but bid-ask spreads can widen on news. Strategy: for AI-focused portfolios, consider a small exposure size, clear stop losses, and monitor the March earnings for revenue milestones. For longer-term investors, follow commercial traction metrics and margin improvement.
Final Thoughts
Key takeaways: BRN.AX stock trades at A$0.175 pre-market on 24 Jan 2026 with heavy volume and wide valuation gaps. Financials show negative EPS (-0.02) and stretched multiples, while technicals are mixed with RSI 60.30. Meyka AI’s forecast model projects A$0.19039 over the next 12 months, implying an 8.79% upside versus today’s price. Meyka AI rates BRN.AX 64.86/100 (Grade B, HOLD) after comparing benchmarks, sector trends, and fundamentals. Investors focused on AI semiconductors should treat BRN.AX as a high-risk growth exposure and watch the 04 Mar 2026 earnings release and any Akida commercial updates before increasing position size. Forecasts are model-based projections and not guarantees, and we note an independent external rating of C- (Strong Sell) for balance.
FAQs
What is the current price of BRN.AX stock?
BRN.AX stock trades at A$0.175 pre-market on 24 Jan 2026. Volume is 8,763,763.00 and market cap is A$412,730,208.00. Watch the intraday A$0.170–A$0.180 band for short-term support and resistance.
What does Meyka AI forecast for BRN.AX stock?
Meyka AI’s forecast model projects A$0.19039 over 12 months for BRN.AX stock, implying an 8.79% upside versus the current price of A$0.175. Forecasts are model-based projections and not guarantees.
What are the main risks for BrainChip (BRN.AX)?
BRN.AX faces execution risk, negative EPS (-0.02), high price-to-sales, and funding dilution risk. Commercial adoption of the Akida processor and upcoming earnings on 04 Mar 2026 are key near-term risk points.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
